Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
DrugsPharmaceutical Industry

Pharmaceutical Industry

What's New from AJM

Why California’s Proposition 61 Was a Bad Idea

0
New approaches to control state pharmaceutical costs are needed.1 This issue is particularly critical in California, the state with the largest pharmaceutical expenditures in the country.1 A controversial California ballot initiative aimed at reining in prescription drug expenditures was defeated on November 8, 2016 by a 54% to 46% margin.2The California Drug Price Relief Act, also known as Proposition 61, sought...